We focused on two high-frequency pathogenic mutations associated with hereditary breast cancer among Japanese patients—the BRCA1 Leu63Ter and the BRCA2 c.5576_5579delTTAA frameshift mutation. Here, BRCA2 is linked to breast carcinoma.